ALS (motor neurone disease) trials in China

In China 20 Also abroad 225

20 trials · From ClinicalTrials.gov, checked 10 November 2026. Ask the study team whether a trial fits you.

Phase 1/2Taking people
TP04HN106 in the Treatment of Patients With Amyotrophic Lateral Sclerosis
Where
Suzhou
Age
18 years and over
People
60
Run by
Talengen Institute of Life Sciences, Shenzhen, P.R. China.
See details and how to joinNCT06726577
Phase 2/3Taking people
A Study to Evaluate the Efficacy and Safety of Different Doses of CB03-154 in Adult Patients With Amyotrophic Lateral Sclerosis (ALS)
Where
Beijing
Age
18 years to 65 years
People
240
Run by
Shanghai Zhimeng Biopharma, Inc.
See details and how to joinNCT07082192
Phase 2Not yet taking people in China
A Phase II Study of ALT001 in Patients With Amyotrophic Lateral Sclerosis (ALS)
Where
Beijing
Age
18 years to 75 years
People
150
Run by
Darwin Origin (Hubei) Biopharmaceutical Co., Ltd.
See details and how to joinNCT07833618
No phaseEnrolling by invitation
Unrelated Umbilical Cord Blood Transplantation for the Treatment of Amyotrophic Lateral Sclerosis (ALS)
Where
Tianjin
Age
35 years to 50 years
People
8
Run by
Institute of Hematology & Blood Diseases Hospital, China
See details and how to joinNCT07539662
Phase 1Taking people
The Safety, Tolerability and Preliminary Efficacy of Derived Motor Neuron Progenitor Cells (XS228CN) in Subjects With Amyotrophic Lateral Sclerosis
Where
Beijing
Age
18 years to 75 years
People
12
Run by
XellSmart Bio-Pharmaceutical (Suzhou) Co., Ltd.
See details and how to joinNCT07118319
Phase 1Taking people
Clinical Study of Regulatory T Cells (Tregs) in the Treatment of Neurodegenerative Diseases
Where
Zhengzhou
Age
18 years to 70 years
People
12
Run by
Novabio Therapeutics
See details and how to joinNCT06671236
Phase 1/2Not yet taking people in China
A Phase Ⅰ/Ⅱa Study of SNUG01 in Adult Subjects With ALS
Where
Beijing, Fuzhou, Hangzhou
Age
18 years to 80 years
People
21 worldwide
Run by
SineuGene Therapeutics Co., Ltd.
See details and how to joinNCT07169175
Phase 1Not yet taking people in China
hUC-MSC-sEV-001 Nasal Drops for Neurodegenerative Diseases
Where
Beijing
Age
18 years to 80 years
People
120
Run by
Xuanwu Hospital, Beijing
See details and how to joinNCT06607900
No phaseTaking people
The Study Evaluating the Improvement of Nutritional Status and Frailty With Silkworm Pupa Powder Among Patients With Motor Neuron Disease
Where
Hangzhou
Age
18 years to 80 years
People
100
Run by
First People's Hospital of Hangzhou
See details and how to joinNCT06765499
Early phase 1Taking people
A Study to Evaluate the Tolerability, Safety and Efficacy of VGN-R13 in Patients with ALS
Where
Wuhan
Age
18 years and over
People
6
Run by
Hong Chen
See details and how to joinNCT06849609
No phaseTaking people
Research on Wireless Brain Implant System for General Control of External Devices
Where
Shanghai
Age
18 years to 80 years
People
4
Run by
Shanghai StairMed Technology Co., Ltd.
See details and how to joinNCT06829212
No phaseTaking people
Clinical Study of Induced Pluripotent Stem Cells Derived Motor Neuron Precursor Cell Therapy for Amyotrophic Lateral Sclerosis (ALS)
Where
Shanghai
Age
18 years to 60 years
People
3
Run by
Shanghai East Hospital
See details and how to joinNCT06765564
Phase 1Taking people
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RAG-17 in Subjects With Amyotrophic Lateral Sclerosis (ALS) With Superoxide Dismutase Type 1 (SOD1) Gene Mutation
Where
Beijing, Chengdu, Hangzhou
Age
18 years and over
People
32
Run by
Ractigen Therapeutics.
See details and how to joinNCT06556394
Early phase 1Not yet taking people in China
Tofacitinib in Patients With Amyotrophic Lateral Sclerosis
Where
Beijing
Age
18 years to 75 years
People
12
Run by
Beijing Tiantan Hospital
See details and how to joinNCT06689982
Early phase 1Not yet taking people in China
An IIT Clinical Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of a Single Intrathecal Injection of SNUG01 in Patients with Amyotrophic Lateral Sclerosis
Where
Beijing, Chengdu, Fujian, Hangzhou, Nanjing
Age
18 years to 80 years
People
7
Run by
Peking University Third Hospital
See details and how to joinNCT06645197
Phase 4Taking people
Clinical Study to Evaluate the Efficacy and Safety of FB1006 in the Treatment of ALS Patients
Where
Beijing
Age
18 years to 80 years
People
64
Run by
Peking University Third Hospital
See details and how to joinNCT05923905
No phaseEnrolling by invitation
Explore Biomarkers of Motor Neuron Disease/Frontal Dementia Spectrum Disease in China
Where
Beijing
Age
18 years to 80 years
People
2,500
Run by
Peking University Third Hospital
See details and how to joinNCT04961450
No phaseTaking people
China Amyotrophic Lateral Sclerosis Registry of Patients With Traditional Chinese Medicine
Where
Beijing
Age
18 years and over
People
2,000
Run by
Dongzhimen Hospital, Beijing
See details and how to joinNCT04885374
No phaseTaking people
A Registered Cohort Study on Amyotrophic Lateral Sclerosis
Where
Fuzhou
People
2,000
Run by
First Affiliated Hospital of Fujian Medical University
See details and how to joinNCT04008329
No phaseTaking people
Natural History and Clinical Features of Amyotrophic Lateral Sclerosis (ALS)
Where
Beijing
People
3,000
Run by
Peking University Third Hospital
See details and how to joinNCT04454892